OPAXIO

Swiss trademark · 579569 · Word mark · Deleted

Register entry

Registration number
579569
Application number
56995/2008
Status
Deleted
Type
Word mark
Filed
Jun 3, 2008
Registered
Nov 25, 2008
Published
Nov 25, 2008
Deleted
Jan 8, 2019
Reason
Not renewed
Priority
04.12.2007 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Erzeugnisse, Arzneimittel und Wirkstoffe zur Verwendung für die Krebsbehandlung; Pharmazeutische Erzeugnisse zur Verwendung bei der Behandlung von immunologischen und entzündlichen Erkrankungen; chemotherapeutische Wirkstoffe; Antibiotika.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 8, 2019

    Deleted, not renewed

    Published in Swissreg on 08.01.2019

  2. Jun 1, 2015

    Transferred

    Owner
    Novartis AG, 4000 Basel → CTI BIOPHARMA CORP., 3101 Western Avenue, Seattle, Washington 98121, USA
    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Jacobacci & Partners SA, Via Luganetto 3, 6962 Lugano

    Published in Swissreg on 01.06.2015

  3. Feb 9, 2010

    Transferred

    Owner
    Cell Therapeutics, Inc., 501 Elliott Avenue West,, Suite 400, Seattle, Washington 98119, USA → Novartis AG, 4000 Basel
    Representative
    Wenger & Vieli Rechtsanwälte, Dufourstrasse 56,, Postfach 1285, 8034 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 09.02.2010

  4. Nov 25, 2008

    Registered

    Published in Swissreg on 25.11.2008

Parties

Holder

CTI BIOPHARMA CORP.

3101 Western Avenue, Seattle, Washington 98121, US

Agent

Jacobacci & Partners SA

Via Luganetto 3, 6962 Lugano

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.